Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 16.08
-0.50 (-3.02%)
At close: Aug 21, 2026
BOM:531015 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 8.22 | 12.24 | 24.82 | 0.03 | 0 | 0 |
Cash & Short-Term Investments | 8.22 | 12.24 | 24.82 | 0.03 | 0 | 0 |
Cash Growth | -67.38% | -50.71% | 99196.00% | 733.33% | 0% | -99.60% |
Accounts Receivable | 16.1 | 14.3 | 9.53 | - | 0.36 | 0.36 |
Other Receivables | 3.52 | 51.61 | 0.27 | 0.13 | - | - |
Receivables | 19.63 | 65.91 | 9.79 | 0.13 | 0.36 | 0.36 |
Inventory | 21.69 | 9.99 | 0.58 | - | - | - |
Other Current Assets | 118.32 | 73.5 | 16.1 | - | 1.02 | 0.96 |
Total Current Assets | 167.86 | 161.64 | 51.29 | 0.16 | 1.38 | 1.33 |
Property, Plant & Equipment | 0.41 | 0.37 | 0.41 | 0.45 | 0.5 | 0.56 |
Other Intangible Assets | - | - | - | 0.21 | 0.23 | 0.26 |
Other Long-Term Assets | - | 0 | -0 | - | - | - |
Total Assets | 168.26 | 162 | 51.7 | 0.81 | 2.11 | 2.14 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 15.33 | 16.77 | 6.29 | 1.03 | 3.29 | 4.71 |
Accrued Expenses | - | - | 0.31 | 1.21 | 1.99 | - |
Short-Term Debt | 2.11 | 2.81 | 0.5 | 3.52 | 3.52 | 3.49 |
Current Income Taxes Payable | - | - | - | 0.22 | - | - |
Other Current Liabilities | 0.74 | 0.74 | 0.48 | 1.29 | 0.42 | 3.3 |
Total Current Liabilities | 18.18 | 20.33 | 7.57 | 7.27 | 9.21 | 11.49 |
Long-Term Debt | - | 0.5 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | 0.01 | 0.05 | 0.05 | 0.05 |
Other Long-Term Liabilities | - | 0 | - | - | - | - |
Total Liabilities | 18.19 | 20.84 | 7.58 | 7.32 | 9.26 | 11.54 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 115.83 | 115.83 | 52.39 | 52.39 | 52.39 | 52.39 |
Additional Paid-In Capital | - | - | - | - | - | 7.3 |
Retained Earnings | - | - | -58.99 | -58.89 | -59.53 | -69.09 |
Comprehensive Income & Other | 34.25 | 25.33 | 50.72 | -0 | - | - |
Shareholders' Equity | 150.08 | 141.16 | 44.12 | -6.5 | -7.15 | -9.4 |
Total Liabilities & Equity | 168.26 | 162 | 51.7 | 0.81 | 2.11 | 2.14 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 2.11 | 3.31 | 0.5 | 3.52 | 3.52 | 3.49 |
Net Cash (Debt) | 6.11 | 8.93 | 24.33 | -3.5 | -3.52 | -3.49 |
Net Cash Growth | -75.26% | -63.31% | - | - | - | - |
Net Cash Per Share | 0.46 | 0.76 | 4.64 | -0.67 | -0.67 | -0.67 |
Filing Date Shares Outstanding | 11.66 | 27.15 | 5.24 | 5.24 | 5.24 | 5.24 |
Total Common Shares Outstanding | 11.66 | 27.15 | 5.24 | 5.24 | 5.24 | 5.24 |
Working Capital | 149.68 | 141.31 | 43.73 | -7.11 | -7.83 | -10.17 |
Book Value Per Share | 12.87 | 5.20 | 8.42 | -1.24 | -1.36 | -1.79 |
Tangible Book Value | 150.08 | 141.16 | 44.12 | -6.71 | -7.38 | -9.66 |
Tangible Book Value Per Share | 12.87 | 5.20 | 8.42 | -1.28 | -1.41 | -1.84 |
Machinery | - | - | - | - | - | 0.62 |